Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Zimmer Biomet Holdings Community
NYSE:ZBH Community
1
Narratives
written by author
0
Comments
on narratives written by author
29
Fair Values set
on narratives written by author
Create a narrative
Zimmer Biomet Holdings
Popular
Undervalued
Overvalued
Community Investing Ideas
Zimmer Biomet Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 26 Analysts
Upcoming Product Launches And Paragon 28 Acquisition Will Strengthen Market Position
Key Takeaways Acquisition of Paragon 28 and product launches target growth in foot, ankle, knees, and hips markets, enhancing Zimmer Biomet's portfolio and revenue opportunities. Expansion into ambulatory surgical centers and operational excellence initiatives expected to boost margins, market share, and financial performance.
View narrative
US$122.35
FV
17.0% undervalued
intrinsic discount
3.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
18
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
ZBH
ZBH
Zimmer Biomet Holdings
Your Fair Value
US$
Current Price
US$101.51
66.9% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-379m
9b
2015
2018
2021
2024
2025
2027
2030
Revenue US$9.3b
Earnings US$1.1b
Advanced
Set Fair Value